
G R Infraprojects bags Rs 1,257 crore contract from BSNL for BharatNet Project in Kerala
The project involves the design, supply, construction, installation, upgradation, operation, and maintenance of the middle-mile network under Package No. 16, as per Tender Enquiry No. MM/BNO&M/BN-III/T-791/2024, dated 15th February 2024.
The contract follows an Advance Work Order (AWO) issued by BSNL on 5th May 2025. The project will be executed under the Design, Build, Operate, and Transfer (DBOT) model. The execution phase is expected to take three years, followed by seven years of operation and maintenance.
With this new contract, G R Infraprojects continues to strengthen its position in the telecommunications and infrastructure sectors. The company's ongoing commitment to quality and timely execution has helped it secure large-scale projects with major national players like BSNL.
As the project progresses, G R Infraprojects will play a pivotal role in shaping the future of digital connectivity in Kerala, contributing to the Government's vision of a digitally inclusive India.
In the meantime, G R Infraprojects shares opened today at ₹1,069.80, reaching a high of ₹1,075.00 and a low of ₹1,045.50 on the trading day. The stock has seen a significant fluctuation over the past year, with its 52-week high at ₹1,860.00 and its 52-week low at ₹901.00.
Aman Shukla is a post-graduate in mass communication . A media enthusiast who has a strong hold on communication ,content writing and copy writing. Aman is currently working as journalist at BusinessUpturn.com
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Business Upturn
5 hours ago
- Business Upturn
Glenmark Pharma receives warning letter from US FDA for Indore facility
By Aman Shukla Published on July 12, 2025, 21:36 IST Glenmark Pharmaceuticals has received a warning letter from the United States Food and Drug Administration (US FDA) concerning its manufacturing facility in Indore, Madhya Pradesh. The regulatory action follows an inspection conducted by the US FDA between February 3 and February 14, 2025. The company clarified that the warning letter is not expected to impact the current supply chain or revenues generated from operations at the Indore site. Importantly, Glenmark stated that the US FDA observations did not include any data integrity issues. 'This warning letter will not affect the availability of our products in the market, and we remain focused on ensuring consistent supply without disruptions,' the company said in a statement. Glenmark reaffirmed its commitment to addressing all the concerns raised by the US FDA and said it is actively working with the agency to resolve the issues at the earliest. The company emphasized its adherence to Current Good Manufacturing Practices (CGMP) and maintaining high standards of quality and compliance across all facilities. This update follows Glenmark's earlier communication on May 9, 2025, regarding the Indore facility being classified as 'Official Action Indicated' (OAI) by the US FDA. Ahmedabad Plane Crash Aman Shukla is a post-graduate in mass communication . A media enthusiast who has a strong hold on communication ,content writing and copy writing. Aman is currently working as journalist at


Business Upturn
9 hours ago
- Business Upturn
TGV SRAAC to set up additional 40 MW solar power plant at Rs 120 crore
TGV SRAAC has announced that its Board of Directors has approved the setting up of a new 40 MW solar power plant at an estimated cost of ₹120 crore. The decision was passed via circular resolution on July 12, 2025. The project will be funded through internal accruals and/or bank finance. The upcoming 40 MW solar plant is expected to be installed near TGV SRAAC's factory or at an alternate suitable location. This expansion aligns with the company's continued focus on sustainable energy and reducing its carbon footprint through clean power generation. Advertisement In the exchagne filings the copmany shared, 'We bring to your kind notice that the Board has given approval by way of Circular Resolution on 12.07 .2025 to the Company for setting up of further 40 MW Solar Power plant near to our Factory/elsewhere at a total approximate cost of Rs.120 Cr funded through internal accruals / Bank finance.' This latest move comes in addition to the company's earlier board approval for a 60 MW solar project—of which 37.90 MW has already been completed and is generating power, while the remaining 22.10 MW is under progress and advancing as planned.


Business Upturn
9 hours ago
- Business Upturn
Amber Enterprises board approves enabling resolution to raise up to Rs 2,500 crore
Amber Enterprises India Ltd has announced that its Board of Directors, at a meeting held on July 12, 2025, has approved an enabling resolution to raise funds of up to ₹2,500 crore. The proposed fundraising will be through the issuance of permissible securities and is subject to necessary regulatory approvals and shareholder consent. This move was disclosed in accordance with Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and follows the company's earlier intimation dated July 9. The company noted that further details regarding the type and mode of securities will be shared in compliance with SEBI's November 2024 circular, once finalized. Additionally, the Board approved the Notice of the 35th Annual General Meeting (AGM), which is scheduled to be held on Monday, August 11, 2025, at 3:00 PM IST. The AGM notice and the Annual Report for FY 2024-25 will be shared with the stock exchanges in due course. Ahmedabad Plane Crash Aman Shukla is a post-graduate in mass communication . A media enthusiast who has a strong hold on communication ,content writing and copy writing. Aman is currently working as journalist at